Q2 2026 Holdings
Filed 2026-08-13 | 14 holdings | $471.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $341.8M | 4,589,611 | 72.5% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $37.6M | 1,555,664 | 8.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $28.8M | 1,316,806 | 6.1% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $20.3M | 1,432,336 | 4.3% |
| Bicara Therapeutics Inc(BCAX) | COM | 055477103 | $16.9M | 568,919 | 3.6% |
| Bridgebio Oncology Therapeut(BBOT) | COM NEW | 107924102 | $7.8M | 1,018,018 | 1.6% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $4.2M | 77,031 | 0.9% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $4.0M | 108,000 | 0.8% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $3.0M | 2,048,757 | 0.6% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $2.3M | 434,455 | 0.5% |
| Eupraxia Pharmaceuticals Inc(EPRX) | COM | 29842P105 | $2.1M | 325,000 | 0.5% |
| VTV Therapeutics Inc(VTVT) | CL A NEW | 918385204 | $1.9M | 50,000 | 0.4% |
| Marker Therapeutics Inc(MRKR) | COM NEW | 57055L206 | $478.3K | 325,370 | 0.1% |
| Onkure Therapeutics Inc(OKUR) | COM CL A | 68277Q105 | $404.0K | 88,607 | 0.1% |